Bioelectronics Corp Stock Short Ratio
| BIEL Stock | USD 0.0003 0.0001 50.00% |
Bioelectronics Corp fundamentals help investors to digest information that contributes to Bioelectronics Corp's financial success or failures. It also enables traders to predict the movement of Bioelectronics Pink Sheet. The fundamental analysis module provides a way to measure Bioelectronics Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bioelectronics Corp pink sheet.
Bioelectronics |
Bioelectronics Corp Company Short Ratio Analysis
Bioelectronics Corp's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Bioelectronics Corp has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Bioelectronics Fundamentals
| Return On Asset | -0.34 | |||
| Profit Margin | (0.18) % | |||
| Operating Margin | (0.09) % | |||
| Current Valuation | 52.16 M | |||
| Shares Outstanding | 24.71 B | |||
| Price To Sales | 30.73 X | |||
| Revenue | 1.61 M | |||
| Gross Profit | 795.53 K | |||
| EBITDA | (1.36 M) | |||
| Net Income | (289.82 K) | |||
| Cash And Equivalents | 925 | |||
| Total Debt | 13.34 M | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (320.3 K) | |||
| Number Of Employees | 10 | |||
| Beta | 0.45 | |||
| Market Capitalization | 12.35 M | |||
| Total Asset | 1.11 M | |||
| Retained Earnings | (28.41 M) | |||
| Working Capital | (5.75 M) | |||
| Current Asset | 1.11 M | |||
| Current Liabilities | 6.86 M | |||
| Z Score | -43.3 |
About Bioelectronics Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bioelectronics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioelectronics Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioelectronics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Bioelectronics Pink Sheet
Bioelectronics Corp financial ratios help investors to determine whether Bioelectronics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioelectronics with respect to the benefits of owning Bioelectronics Corp security.